Cargando…
Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice
We investigated the effect of fenofibrate nano-eyedrops (FenoNano) on impaired retinal blood flow regulation in type 2 diabetic mice. Six-week-old db/db mice were randomly divided into an untreated group (n = 6) and treated group, which received FenoNano (n = 6). The longitudinal changes in retinal...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876509/ https://www.ncbi.nlm.nih.gov/pubmed/35214116 http://dx.doi.org/10.3390/pharmaceutics14020384 |
_version_ | 1784658191869542400 |
---|---|
author | Hanaguri, Junya Nagai, Noriaki Yokota, Harumasa Kushiyama, Akifumi Watanabe, Masahisa Yamagami, Satoru Nagaoka, Taiji |
author_facet | Hanaguri, Junya Nagai, Noriaki Yokota, Harumasa Kushiyama, Akifumi Watanabe, Masahisa Yamagami, Satoru Nagaoka, Taiji |
author_sort | Hanaguri, Junya |
collection | PubMed |
description | We investigated the effect of fenofibrate nano-eyedrops (FenoNano) on impaired retinal blood flow regulation in type 2 diabetic mice. Six-week-old db/db mice were randomly divided into an untreated group (n = 6) and treated group, which received FenoNano (n = 6). The longitudinal changes in retinal neuronal function and blood flow responses to systemic hyperoxia and flicker stimulation were evaluated every 2 weeks in diabetic db/db mice treated with FenoNano (n = 6) or the vehicle (n = 6) from ages 8–14 weeks. The retinal blood flow was assessed using laser speckle flowgraphy. We also evaluated the expressions of vascular endothelial growth factor (VEGF), glial fibrillary acidic protein (GFAP), and aquaporin 4 (AQP4) and the phosphorylation of peroxisome proliferator-activated receptor alpha (PPAR-α) by immunofluorescence. In db/db mice treated with FenoNano, both responses were restored from 8 to 14 weeks of age compared with the diabetic mice treated with the vehicle. At 14 weeks of age, the impaired regulation of retinal blood flow during systemic hyperoxia and flicker stimulation improved to about half of that in the db/db mice treated with FenoNano compared with the db/m control group (n = 5). FenoNano prevented the activation of VEGF and GFAP expression and increased the AQP4 expression and the phosphorylation of PPAR-α detected by immunofluorescence compared with the diabetic mice treated with the vehicle eyedrop. Our results suggested that the fenofibrate nano-eyedrops prevent retinal glial dysfunction via the phosphorylation of PPAR-α and improves the retinal blood flow dysregulation in type 2 diabetic mice. |
format | Online Article Text |
id | pubmed-8876509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88765092022-02-26 Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice Hanaguri, Junya Nagai, Noriaki Yokota, Harumasa Kushiyama, Akifumi Watanabe, Masahisa Yamagami, Satoru Nagaoka, Taiji Pharmaceutics Article We investigated the effect of fenofibrate nano-eyedrops (FenoNano) on impaired retinal blood flow regulation in type 2 diabetic mice. Six-week-old db/db mice were randomly divided into an untreated group (n = 6) and treated group, which received FenoNano (n = 6). The longitudinal changes in retinal neuronal function and blood flow responses to systemic hyperoxia and flicker stimulation were evaluated every 2 weeks in diabetic db/db mice treated with FenoNano (n = 6) or the vehicle (n = 6) from ages 8–14 weeks. The retinal blood flow was assessed using laser speckle flowgraphy. We also evaluated the expressions of vascular endothelial growth factor (VEGF), glial fibrillary acidic protein (GFAP), and aquaporin 4 (AQP4) and the phosphorylation of peroxisome proliferator-activated receptor alpha (PPAR-α) by immunofluorescence. In db/db mice treated with FenoNano, both responses were restored from 8 to 14 weeks of age compared with the diabetic mice treated with the vehicle. At 14 weeks of age, the impaired regulation of retinal blood flow during systemic hyperoxia and flicker stimulation improved to about half of that in the db/db mice treated with FenoNano compared with the db/m control group (n = 5). FenoNano prevented the activation of VEGF and GFAP expression and increased the AQP4 expression and the phosphorylation of PPAR-α detected by immunofluorescence compared with the diabetic mice treated with the vehicle eyedrop. Our results suggested that the fenofibrate nano-eyedrops prevent retinal glial dysfunction via the phosphorylation of PPAR-α and improves the retinal blood flow dysregulation in type 2 diabetic mice. MDPI 2022-02-09 /pmc/articles/PMC8876509/ /pubmed/35214116 http://dx.doi.org/10.3390/pharmaceutics14020384 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hanaguri, Junya Nagai, Noriaki Yokota, Harumasa Kushiyama, Akifumi Watanabe, Masahisa Yamagami, Satoru Nagaoka, Taiji Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice |
title | Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice |
title_full | Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice |
title_fullStr | Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice |
title_full_unstemmed | Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice |
title_short | Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice |
title_sort | fenofibrate nano-eyedrops ameliorate retinal blood flow dysregulation and neurovascular coupling in type 2 diabetic mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876509/ https://www.ncbi.nlm.nih.gov/pubmed/35214116 http://dx.doi.org/10.3390/pharmaceutics14020384 |
work_keys_str_mv | AT hanagurijunya fenofibratenanoeyedropsameliorateretinalbloodflowdysregulationandneurovascularcouplingintype2diabeticmice AT nagainoriaki fenofibratenanoeyedropsameliorateretinalbloodflowdysregulationandneurovascularcouplingintype2diabeticmice AT yokotaharumasa fenofibratenanoeyedropsameliorateretinalbloodflowdysregulationandneurovascularcouplingintype2diabeticmice AT kushiyamaakifumi fenofibratenanoeyedropsameliorateretinalbloodflowdysregulationandneurovascularcouplingintype2diabeticmice AT watanabemasahisa fenofibratenanoeyedropsameliorateretinalbloodflowdysregulationandneurovascularcouplingintype2diabeticmice AT yamagamisatoru fenofibratenanoeyedropsameliorateretinalbloodflowdysregulationandneurovascularcouplingintype2diabeticmice AT nagaokataiji fenofibratenanoeyedropsameliorateretinalbloodflowdysregulationandneurovascularcouplingintype2diabeticmice |